Roche

An arrow incrementally going up stairs before pointing straight up Blue background
Biotech

Roche links SERD to 30% breast cancer risk reduction in phase 3

Roche reported a 30% reduction in the risk of invasive disease recurrence or death in patients on its oral selective estrogen receptor degrader.
Nick Paul Taylor Dec 10, 2025 8:15am
Optimization of Business Processes with Gears

Paradigm snags $78M to revamp CRO space, inks deal with Flatiron

Dec 4, 2025 2:35pm
whooping cough bordetella pertussis

Roche whooping cough test greenlighted in US, Europe

Dec 2, 2025 10:55am
Graphic image of an arrow nailing the bullseye of a target

Roche's oral SERD hits goal in adjuvant breast cancer phase 3

Nov 18, 2025 9:16am
yellow traffic light

Zealand pumps brakes on development of dual GLP-1/GLP-2 agonist

Nov 13, 2025 9:52am
Image comparing healthy and degraded myelin sheath

Roche reports phase 3 multiple sclerosis wins for BTK inhibitor

Nov 10, 2025 6:26am